Reid Health
Richmond, Indiana, United States
General hospital in Richmond, Indiana
1100 Reid Pkwy, Richmond, IN 47374
About Reid Health
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
144
Alliance for Clinical Trials in Oncology
85
SWOG Cancer Research Network
78
ECOG-ACRIN Cancer Research Group
25
NRG Oncology
7
NSABP Foundation Inc
7
Eastern Cooperative Oncology Group
5
Radiation Therapy Oncology Group
5
Bayer
4
Gynecologic Oncology Group
4
GOG Foundation
3
Clinical Trials at Reid Health
During the past decade, Reid Health conducted 130 clinical trials. In the 10-year time frame, 130 clinical trials started and 185 clinical trials were completed, i.e. on
average, 142.3% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 66 clinical trials were completed. i.e. 178.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
2000-01-01
2010-03-01
Terminated
589
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
2002-11-01
2009-12-01
Completed
671
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Reid Health" #1 sponsor was "National Cancer Institute (NCI)" with 144 trials, followed by "Alliance for Clinical Trials in Oncology" with 85 trials
sponsored, "SWOG Cancer Research Network" with 78 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 25 trials sponsored and "NRG Oncology"
with 25 trials sponsored. Other sponsors include 35 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Reid Health"
#1 collaborator was "National Cancer Institute (NCI)" with 222 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator and "Canadian Cancer Trials Group" with 9 trials as a collaborator. Other collaborators include 64 different institutions and companies that were
collaborators in the rest 44 trials.
Clinical Trials Conditions at Reid Health
According to Clinical.Site data, the most researched conditions in "Reid Health" are
"Breast Cancer" (32 trials), "Lymphoma" (21 trials), "Lung Cancer" (17 trials), "Recurrent Breast Carcinoma" (13 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials). Many other conditions were trialed in "Reid Health" in a lesser frequency.
Clinical Trials Intervention Types at Reid Health
Most popular intervention types in "Reid Health" are "Drug" (317 trials), "Other" (199 trials), "Biological" (151 trials), "Procedure" (74 trials) and "Radiation" (55 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (90 trials), "Quality-of-Life Assessment" (60 trials), "Paclitaxel" (36 trials), "Carboplatin" (35 trials) and "Questionnaire Administration" (31 trials). Other intervention names were less common.
Clinical Trials Genders at Reid Health
The vast majority of trials in "Reid Health" are
314 trials for "All" genders, 54 trials for "Female" genders and 11 trials for "Male" genders.
Clinical Trials Status at Reid Health
Currently, there are NaN active trials in "Reid Health".
undefined are not yet recruiting,
58 are recruiting,
118 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 164 completed trials in Reid Health,
3 suspended trials,
and 32 terminated clinical trials to date.
Out of the total trials that were conducted in Reid Health, 10 "Phase 1"
clinical trials were conducted, 196 "Phase 2" clinical
trials and 168 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 9 trials that are defined as “Not Applicable".